ASCO - but where is SPL clinical data?

Asco abstracts were released for this week big conference and I was hoping naïve that starpharma would be presenting phase 2 results. sadly this not the strategy of jacky and Dr Paul so another year goes by with no data at important meeting where all oncology experts go.

Dr Paul VP linked in say he a research scientist before he join SPL over 20 years ago to head regulatory and clinal studies so he need to go to ASCO get new consultants to run a fast study to get useful data for drug registration. The lack of experience showing up now and need someone with real skills not just over paid puppet.

dep docetaxel phase 2 trial has been going on for so many years since 2017 and dep cabazitaxel phase 2 since 2019. These are small study with not many patients, not enough for registration.and new arms keep be added and it seem like bad sign. These should be completed already. Is this incompetence or is DEP not worth the hype? The sooner Astra zeneca get proper data the sooner we will know.